ArticleEuropean heart journal. Case reports2026
Lithotripsy-assisted TAVR for severe calcific aortic stenosis. Case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: TAVR has become the first option in several scenarios for the treatment of aortic stenosis. Nevertheless, calcium can lead to suboptimal outcomes concerning paravalvular leak and annular rupture. In this context, novel therapies have been emerging; intravascular lithotripsy (IVL) with Shockwave balloons is one of the most recent, with promising results, although more research is needed to propose this kind of therapy in this context. Case summary: We present the case of a 78-year-old woman with severe calcific aortic stenosis and a very small annulus, treated with intravascular lithotripsy. Sequential IVL balloon inflations (two 7.0 × 40 mm balloons, then an 8.0 × 40 mm balloon) were performed, followed by an 18 mm valvuloplasty balloon and deployment of a 23 mm Accurat Neo2. The procedure achieved an excellent final result with no complications, no paravalvular leak, and favourable early outcomes at 6 months. Discussion: This case highlights the novel use of these types of calcium-modifying devices for other than coronary and peripheral vessels with promising outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.